Mechanism

MGF E-domain cell response

Synthetic peptides derived from the E-domain of the IGF-1Ec splice variant have been investigated for effects on progenitor-cell proliferation, survival, migration and differentiation.

Use for MGF and PEG-MGF while clearly separating endogenous IGF-1 splice-variant biology from synthetic peptide claims.
00

Biological pathway

Synthetic MGF E-domain peptide exposure → incompletely defined receptor or membrane interaction → context-dependent changes in progenitor-cell proliferation, survival and differentiation.

00b

Evidence summary

Some cell and animal studies report biological activity, but other laboratories have failed to reproduce key muscle-cell findings and the endogenous existence of a freely circulating MGF E-peptide remains disputed.

00c

Limitations

The receptor is not established, peptide identity varies between studies and vendor products, and laboratory effects do not establish human muscle recovery or hypertrophy.
01

Peptides linked to this mechanism

Explore further

from the knowledge graph
ImportantPeptiBrief is an educational information platform. It does not diagnose, prescribe, sell peptides, recommend dosing, encourage self-experimentation or replace qualified medical care. Published scientific evidence is kept separate from community observations and uncertainty.